At a time when the local market is assuming the centre stage of the growth strategy for Indian pharma companies, multinational drugmakers are restructuring their businesses in India - by selling brands, closing non-core units, or laying off employees.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7oBpMjR
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Why MNC pharma companies are realigning their India operations
0 comments:
Post a Comment